Both the HPH staff and VHVs understood G6PD-deficiency, the need for G6PD testing prior to treatment, as well as the importance of rigorous follow-up of study participants to monitor potential adverse events. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.